The treatment of idiopathic thrombocytopenic purpura, now also known as primary immune thrombocytopenia, varies from person to person and is difficult to determine. It is recommended to actively receive treatment to improve the symptoms. 1. Primary immune thrombocytopenia is an acquired autoimmune disease in which multiple mechanisms are involved, and is mainly characterized by recurrent cutaneous and mucosal bleeding such as petechiae, ecchymoses, and purpura. The disease is an autoimmune disease and there is no cure. However, if you accept the treatment actively, you can live with the disease for a long time and return to normal life. 2. The specific treatment for primary immune thrombocytopenia varies from person to person, and the therapeutic effect also varies according to the individual’s physique, so it is difficult to make a definite conclusion. Generally, glucocorticoid therapy can be considered, taking drugs such as prednisone and dexamethasone, and splenectomy can also be performed if necessary. In addition, gammaglobulin, human thrombopoietin, azathioprine, rituximab, decitabine, etc. are also common medications used to treat primary immune thrombocytopenia. Please follow your doctor’s instructions for specific treatment regimens.